Covered recipient · General Payments record
NATALIE BORODOKER
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$2,242.27
- Reported across 106 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $762.60 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $202.74 | 16 |
| Bausch & Lomb Americas Inc. | $175.60 | 4 |
| Harrow Eye, LLC | $101.50 | 4 |
| BIOTISSUE HOLDINGS INC. | $94.15 | 3 |
| ABBVIE INC. | $51.43 | 2 |
| Alcon Laboratories Inc | $46.52 | 2 |
| Thea Pharma Inc. | $42.06 | 2 |
| Tarsus Pharmaceuticals, Inc. | $30.41 | 1 |
| Oyster Point Pharma, Inc. | $18.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.41 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103349942 | CMS |
| ABBVIE INC. | $24.02 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103349944 | CMS |
| Alcon Vision LLC | $18.47 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110591333 | CMS |
| Alcon Vision LLC | $28.05 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110591335 | CMS |
| Amgen Inc. | $17.62 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115458410 | CMS |
| Amgen Inc. | $9.91 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115458415 | CMS |
| Amgen Inc. | $6.09 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115458421 | CMS |
| Amgen Inc. | $17.05 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115458425 | CMS |
| Amgen Inc. | $21.15 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115458430 | CMS |
| Amgen Inc. | $17.37 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115458436 | CMS |
| Amgen Inc. | $7.78 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115458443 | CMS |
| Amgen Inc. | $7.92 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115458439 | CMS |
| Amgen Inc. | $7.50 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115458451 | CMS |
| Amgen Inc. | $9.44 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115458447 | CMS |
| Amgen Inc. | $9.17 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115458455 | CMS |
| Amgen Inc. | $9.65 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115458459 | CMS |
| Amgen Inc. | $19.67 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115458463 | CMS |
| Amgen Inc. | $11.20 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115458467 | CMS |
| Amgen Inc. | $12.55 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115458471 | CMS |
| Amgen Inc. | $18.67 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115458474 | CMS |
| Bausch & Lomb Americas Inc. | $12.50 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140417443 | CMS |
| Bausch & Lomb Americas Inc. | $129.59 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140417449 | CMS |
| Bausch & Lomb Americas Inc. | $13.39 | 03/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140417445 | CMS |
| Bausch & Lomb Americas Inc. | $20.12 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140417447 | CMS |
| BIOTISSUE HOLDINGS INC. | $59.63 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148747452 | CMS |
| BIOTISSUE HOLDINGS INC. | $21.15 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148750836 | CMS |
| BIOTISSUE HOLDINGS INC. | $13.37 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148776815 | CMS |
| Harrow Eye, LLC | $30.21 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145598695 | CMS |
| Harrow Eye, LLC | $21.14 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145598697 | CMS |
| Harrow Eye, LLC | $24.86 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145598699 | CMS |
| Harrow Eye, LLC | $25.29 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145598701 | CMS |
| Oyster Point Pharma, Inc. | $18.19 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147416482 | CMS |
| Tarsus Pharmaceuticals, Inc. | $30.41 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139083939 | CMS |
| Thea Pharma Inc. | $19.22 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074539531 | CMS |
| Thea Pharma Inc. | $22.84 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074539533 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.